MedTrace Logo

Comparison of Barrier Products in the Prevention of Incontinence-associated Dermatitis in Hospitalized Elderly

NCT03309059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2018-08-02

No results posted yet for this study

Summary

In clinical practice, there are a large number of patients hospitalized with Incontinence-Associated Dermatitis. Studies are needed to determine the effectiveness of products available for disease prevention. It is believed that the use of the non-irritant barrier film is superior to the use of zinc oxide in the prevention of Incontinence-Associated Dermatitis. The objective of this study is to compare the effect of the use of zinc oxide ointment with the use of non-irritant barrier film in the prevention of diaper dermatitis in incontinent patients admitted to medical clinic units.

Conditions

  • Diaper Rash

Interventions

DEVICE

water and soap

Use of soap and water in the area and subsequent diaper placement disposable.

DEVICE

zinc oxide

Use of soap and water sanitation and application of zinc oxide.

DEVICE

Non-Irritant Barrier Film

Use of soap and water hygiene and application of Non Irritant Barrier Film.

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do estado de Minas Gerais

    collaborator OTHER

  • Federal University of Minas Gerais

    lead OTHER

Principal Investigators

  • Tania C Machado Chianca, Phd · Federal University of Minas Gerais

  • Flavia F Ercole, Phd · Federal University of Minas Gerais

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-11-30
Completion
2018-08-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03309059 on ClinicalTrials.gov